276 related articles for article (PubMed ID: 19582838)
1. Effects of alendronate on bone formation and osteoclastic resorption after implantation of beta-tricalcium phosphate.
Tanaka T; Saito M; Chazono M; Kumagae Y; Kikuchi T; Kitasato S; Marumo K
J Biomed Mater Res A; 2010 May; 93(2):469-74. PubMed ID: 19582838
[TBL] [Abstract][Full Text] [Related]
2. Local application of alendronate controls bone formation and β-tricalcium phosphate resorption induced by recombinant human bone morphogenetic protein-2.
Kitasato S; Tanaka T; Chazono M; Komaki H; Kakuta A; Inagaki N; Akiyama S; Marumo K
J Biomed Mater Res A; 2020 Mar; 108(3):528-536. PubMed ID: 31702866
[TBL] [Abstract][Full Text] [Related]
3. Effects of the systemic administration of alendronate on bone formation in a porous hydroxyapatite/collagen composite and resorption by osteoclasts in a bone defect model in rabbits.
Sugata Y; Sotome S; Yuasa M; Hirano M; Shinomiya K; Okawa A
J Bone Joint Surg Br; 2011 Apr; 93(4):510-6. PubMed ID: 21464492
[TBL] [Abstract][Full Text] [Related]
4. Human osteoclast formation and activity in vitro: effects of alendronate.
Breuil V; Cosman F; Stein L; Horbert W; Nieves J; Shen V; Lindsay R; Dempster DW
J Bone Miner Res; 1998 Nov; 13(11):1721-9. PubMed ID: 9797481
[TBL] [Abstract][Full Text] [Related]
5. The effect of the microstructure of beta-tricalcium phosphate on the metabolism of subsequently formed bone tissue.
Okuda T; Ioku K; Yonezawa I; Minagi H; Kawachi G; Gonda Y; Murayama H; Shibata Y; Minami S; Kamihira S; Kurosawa H; Ikeda T
Biomaterials; 2007 Jun; 28(16):2612-21. PubMed ID: 17316789
[TBL] [Abstract][Full Text] [Related]
6. Bone formation and resorption of highly purified beta-tricalcium phosphate in the rat femoral condyle.
Kondo N; Ogose A; Tokunaga K; Ito T; Arai K; Kudo N; Inoue H; Irie H; Endo N
Biomaterials; 2005 Oct; 26(28):5600-8. PubMed ID: 15878364
[TBL] [Abstract][Full Text] [Related]
7. Localisation of osteogenic and osteoclastic cells in porous beta-tricalcium phosphate particles used for human maxillary sinus floor elevation.
Zerbo IR; Bronckers AL; de Lange G; Burger EH
Biomaterials; 2005 Apr; 26(12):1445-51. PubMed ID: 15482833
[TBL] [Abstract][Full Text] [Related]
8. Basic research and clinical application of beta-tricalcium phosphate (β-TCP).
Tanaka T; Komaki H; Chazono M; Kitasato S; Kakuta A; Akiyama S; Marumo K
Morphologie; 2017 Sep; 101(334):164-172. PubMed ID: 28462796
[TBL] [Abstract][Full Text] [Related]
9. Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro.
Idris AI; Rojas J; Greig IR; Van't Hof RJ; Ralston SH
Calcif Tissue Int; 2008 Mar; 82(3):191-201. PubMed ID: 18259679
[TBL] [Abstract][Full Text] [Related]
10. rhBMP-2 not alendronate combined with HA-TCP biomaterial and distraction osteogenesis enhance bone formation.
Ni M; Li G; Tang PF; Chan KM; Wang Y
Arch Orthop Trauma Surg; 2011 Nov; 131(11):1469-76. PubMed ID: 21805359
[TBL] [Abstract][Full Text] [Related]
11. Osteoinduction with highly purified beta-tricalcium phosphate in dog dorsal muscles and the proliferation of osteoclasts before heterotopic bone formation.
Kondo N; Ogose A; Tokunaga K; Umezu H; Arai K; Kudo N; Hoshino M; Inoue H; Irie H; Kuroda K; Mera H; Endo N
Biomaterials; 2006 Sep; 27(25):4419-27. PubMed ID: 16690121
[TBL] [Abstract][Full Text] [Related]
12. Bone formation and bioresorption after implantation of injectable beta-tricalcium phosphate granules-hyaluronate complex in rabbit bone defects.
Chazono M; Tanaka T; Komaki H; Fujii K
J Biomed Mater Res A; 2004 Sep; 70(4):542-9. PubMed ID: 15307158
[TBL] [Abstract][Full Text] [Related]
13. The deceiving appearances of osteoclasts.
Glowacki J
N Engl J Med; 2009 Jan; 360(1):80-2. PubMed ID: 19118309
[No Abstract] [Full Text] [Related]
14. The bone resorption inhibitors odanacatib and alendronate affect post-osteoclastic events differently in ovariectomized rabbits.
Jensen PR; Andersen TL; Pennypacker BL; Duong LT; Delaissé JM
Calcif Tissue Int; 2014 Feb; 94(2):212-22. PubMed ID: 24085265
[TBL] [Abstract][Full Text] [Related]
15. Electron microscopic study on bone formation and bioresorption after implantation of beta-tricalcium phosphate in rabbit models.
Chazono M; Tanaka T; Kitasato S; Kikuchi T; Marumo K
J Orthop Sci; 2008 Nov; 13(6):550-5. PubMed ID: 19089543
[TBL] [Abstract][Full Text] [Related]
16. Bone healing and graft resorption of autograft, anorganic bovine bone and beta-tricalcium phosphate. A histologic and histomorphometric study in the mandibles of minipigs.
Jensen SS; Broggini N; Hjørting-Hansen E; Schenk R; Buser D
Clin Oral Implants Res; 2006 Jun; 17(3):237-43. PubMed ID: 16672017
[TBL] [Abstract][Full Text] [Related]
17. Ectopic bone formation associated with recombinant human bone morphogenetic proteins-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers.
Kim CS; Kim JI; Kim J; Choi SH; Chai JK; Kim CK; Cho KS
Biomaterials; 2005 May; 26(15):2501-7. PubMed ID: 15585252
[TBL] [Abstract][Full Text] [Related]
18. [Repair of cranial defects with bone marrow derived mesenchymal stem cells and beta-TCP scaffold in rabbits].
Bo B; Wang CY; Guo XM
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2003 Jul; 17(4):335-8. PubMed ID: 12920731
[TBL] [Abstract][Full Text] [Related]
19. Effect of systemic parathyroid hormone (1-34) and a beta-tricalcium phosphate biomaterial on local bone formation in a critical-size rat calvarial defect model.
Yun JI; Wikesjö UM; Borke JL; Bisch FC; Lewis JE; Herold RW; Swiec GD; Wood JC; McPherson JC
J Clin Periodontol; 2010 May; 37(5):419-26. PubMed ID: 20236187
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of crude bone morphogenetic protein-induced new bone formation and normalization of endochondral ossification by bisphosphonate treatment in osteoprotegerin-deficient mice.
Tabuchi M; Miyazawa K; Kimura M; Maeda H; Kawai T; Kameyama Y; Goto S
Calcif Tissue Int; 2005 Oct; 77(4):239-49. PubMed ID: 16193235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
